Unusual organization of desmin intermediate filaments in muscular dysgenesis and TTX-treated myotubes

Developmental Biology
A M TassinF Rieger

Abstract

Cytoskeletal intermediate filaments were studied in muscular dysgenesis (mdg) and tetrodotoxin-treated inactive mouse embryo muscle cultures during myofibrillogenesis. Both muscular dysgenesis and tetrodotoxin-treated muscles are characterized in vitro by a total lack of contractile activity and an abnormal development of myofibrils. We studied the organization of the microtubule and intermediate filament networks with immunofluorescence, using anti-tubulin, anti-vimentin, and anti-desmin antibodies during normal and mdg/mdg myogenesis in vitro. Mdg/mdg myotubes present a heterogeneous microtubule network with scattered areas of decreased microtubule density. At the myoblast stage, cells expressed both vimentin and desmin. After fusion only desmin expression is revealed. In mutant myotubes the desmin network remains in a diffuse position and does not reorganize itself transversely, as it does during normal myogenesis. The absence of a mature organization of the desmin network in mdg/mdg myotubes is accompanied by a lack of organization of myofibrils. The role of muscle activity in the organization of myofibrils and desmin filaments was tested in two ways: (i) mdg/mdg myotubes were rendered active by coculturing with normal spin...Continue Reading

References

Jan 1, 1977·Journal of Neuropathology and Experimental Neurology·B Q Banker
Aug 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·E Lazarides, B L Granger
Jan 1, 1979·Annals of the New York Academy of Sciences·A Platzer
Oct 15, 1978·Experimental Cell Research·C Walker, R Strohman
Mar 1, 1976·The Journal of Cell Biology·P Cooke
Jan 1, 1986·Cell Motility and the Cytoskeleton·S Forry-SchaudiesH Holtzer
Jan 1, 1985·The Journal of Cell Biology·A M TassinM Bornens
Aug 1, 1973·Journal of Cellular Physiology·J A Powell, D M Fambrough
Jan 1, 1970·Current Topics in Developmental Biology·D A Fischman
Mar 1, 1972·Developmental Biology·F Bowden-Essien
May 1, 1972·Developmental Biology·A C Platzer, S Gluecksohn-Waelsch
Mar 1, 1969·The Anatomical Record·D E Kelly
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·Y ToyamaH Holtzer
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·K DellagiD Paulin
Jul 1, 1984·The Journal of Cell Biology·P M SteinertR D Goldman
Jan 1, 1982·Cold Spring Harbor Symposia on Quantitative Biology·H HoltzerY Toyama
Jan 1, 1982·Reproduction, Nutrition, Development·M Pinçon-Raymond, F Rieger
Sep 1, 1981·Journal of Muscle Research and Cell Motility·R C StrohmanC R Walker
Dec 6, 1963·Science·S GLUECKSOHN-WAELSCH

❮ Previous
Next ❯

Citations

Aug 1, 1991·Developmental Biology·C Franzini-ArmstrongF Rieger
Apr 1, 1994·Differentiation; Research in Biological Diversity·R B Cary, M W Klymkowsky
May 22, 2001·Molecular Biology of the Cell·C E Torgan, M P Daniels
Jun 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·J VajsarE G Murphy
Sep 15, 1992·European Journal of Biochemistry·J V SmallL E Thornell
Nov 21, 2000·Developmental Dynamics : an Official Publication of the American Association of Anatomists·G Chanas-SacréP Leprince
May 1, 1990·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·H B Sarnat
Feb 9, 2022·Experimental Biology and Medicine·Geyse GomesManoel Luis Costa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.